CLASS II ONGOING Device recall · Reported 15 Oct 2025 · FDA Enforcement Report

EverPatch+, REF: 1044002, Permanent Scleral Reinforcement Matrix recalled

Corneat Vision is recalling EverPatch+, REF: 1044002, Permanent Scleral Reinforcement Matrix, distributed nationwide in the US. The recall was initiated on 18 Aug 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll Lots/ UDI: G16010440020
Quantity recalled180 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0040-2026
FDA event ID
97463
Recalling firm
Corneat Vision, Ra'Anana
Classification
Class II
Status
Ongoing
Recall initiated
18 Aug 2025
FDA classified
3 Oct 2025
Reported
15 Oct 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

18 Aug 2025Recall initiated by company
3 Oct 2025Classified by FDA+46 days
15 Oct 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Reviewed complaints have identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.

Product as listed by the FDA

EverPatch+, REF: 1044002, Permanent Scleral Reinforcement Matrix 1x5.0mm x 8.5 mm Shield/1 x 5.0mm x 6.5 mm Rectangle, STERILE VH202

Where it was distributed

Worldwide - US Nationwide distribution in the states of AZ, CA, CO, CT, DC, DE, FL, GA, ID, IL, IN, KS, MA, MD, MI, MN, MO, MT, NC, NY, OH, PA, SC, TN, TX, UT, VA, WA, WI and the countries of Japan, Israel, Argentina, Hong Kong.

Nationwide ArizonaCaliforniaColoradoConnecticutDistrict of ColumbiaDelawareFloridaGeorgiaIdahoIllinoisIndianaKansasMassachusettsMarylandMichiganMinnesotaMissouriMontanaNorth CarolinaNew York

Questions about this recall

Why was it recalled?

Reviewed complaints have identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.

Which lots are affected?

All Lots/ UDI: G16010440020

Where was it sold?

Worldwide - US Nationwide distribution in the states of AZ, CA, CO, CT, DC, DE, FL, GA, ID, IL, IN, KS, MA, MD, MI, MN, MO, MT, NC, NY, OH, PA, SC, TN, TX, UT, VA, WA, WI and the countries of Japan, Israel, Argentina, Hong Kong.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 97463

This product is part of a recall event; the main page for the event is CorNeat EverPatch recalled by Corneat Vision.

ReportedClassRecallCompanyReasonWhere
CLASS IICorNeat EverPatch recalled by Corneat VisionCorneat VisionOtherNationwide

More recalls from Corneat Vision

All 3
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IICorNeat EverPatch recalled by Corneat VisionCorneat VisionOtherNationwide
DeviceCLASS IICorNeat EverPatch recalled by Corneat VisionCorneat VisionOtherNationwide

Other Other Medical Devices recalls

All 13,884